BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vasilaki A, Thermos K. Somatostatin analogues as therapeutics in retinal disease. Pharmacology & Therapeutics 2009;122:324-33. [DOI: 10.1016/j.pharmthera.2009.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Dal Monte M, Latina V, Cupisti E, Bagnoli P. Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn-Schmiedeberg's Arch Pharmacol 2012;385:481-94. [DOI: 10.1007/s00210-012-0735-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
2 Triebel J, Macotela Y, de la Escalera GM, Clapp C. Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy. IUBMB Life 2011;63:806-10. [PMID: 21913303 DOI: 10.1002/iub.518] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
3 Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-136. [PMID: 20580421 DOI: 10.1016/s0140-6736(09)62124-3] [Cited by in Crossref: 1268] [Cited by in F6Publishing: 637] [Article Influence: 105.7] [Reference Citation Analysis]
4 Kokona D, Charalampopoulos I, Pediaditakis I, Gravanis A, Thermos K. The neurosteroid dehydroepiandrosterone (DHEA) protects the retina from AMPA-induced excitotoxicity: NGF TrkA receptor involvement. Neuropharmacology 2012;62:2106-17. [PMID: 22269901 DOI: 10.1016/j.neuropharm.2012.01.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
5 Wu W, Zhou Y, Wang Y, Liu L, Lou J, Deng Y, Zhao P, Shao A. Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma. Front Oncol 2020;10:1633. [PMID: 33014821 DOI: 10.3389/fonc.2020.01633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Radojevic V, Bodmer D. Expression and localization of somatostatin receptor types 3, 4 and 5 in the wild-type, SSTR1 and SSTR1/SSTR2 knockout mouse cochlea. Cell Tissue Res 2014;358:717-27. [DOI: 10.1007/s00441-014-1977-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Gábriel R. Neuropeptides and diabetic retinopathy. Br J Clin Pharmacol 2013;75:1189-201. [PMID: 23043302 DOI: 10.1111/bcp.12003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
8 Farrell SR, Raymond ID, Foote M, Brecha NC, Barnes S. Modulation of voltage-gated ion channels in rat retinal ganglion cells mediated by somatostatin receptor subtype 4. J Neurophysiol 2010;104:1347-54. [PMID: 20573967 DOI: 10.1152/jn.00098.2010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
9 Kiagiadaki F, Savvaki M, Thermos K. Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity. Neuropharmacology 2010;58:297-303. [PMID: 19576912 DOI: 10.1016/j.neuropharm.2009.06.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
10 Kunjara S, Greenbaum AL, Sochor M, Flyvbjerg A, Grønbaek H, McLean P. Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes. Int J Exp Pathol 2014;95:95-100. [PMID: 24602114 DOI: 10.1111/iep.12069] [Reference Citation Analysis]
11 Zhang Y, Wu N, Li Q, Hu X, Wang L, Sun JG, Wang Z, Sun XH. Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma. Exp Eye Res 2021;204:108449. [PMID: 33465395 DOI: 10.1016/j.exer.2021.108449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kokona D, Mastrodimou N, Pediaditakis I, Charalampopoulos I, Schmid HA, Thermos K. Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies. Exp Eye Res 2012;103:90-8. [PMID: 22960304 DOI: 10.1016/j.exer.2012.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 23.3] [Reference Citation Analysis]
14 Kokona D, Georgiou PC, Kounenidakis M, Kiagiadaki F, Thermos K. Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease. Neural Plast 2016;2016:8373020. [PMID: 26881135 DOI: 10.1155/2016/8373020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kalomiraki M, Thermos K, Chaniotakis NA. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomedicine 2016;11:1-12. [PMID: 26730187 DOI: 10.2147/IJN.S93069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
16 Szabadfi K, Pinter E, Reglodi D, Gabriel R. Neuropeptides, trophic factors, and other substances providing morphofunctional and metabolic protection in experimental models of diabetic retinopathy. Int Rev Cell Mol Biol. 2014;311:1-121. [PMID: 24952915 DOI: 10.1016/b978-0-12-800179-0.00001-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
17 Šarić B, Brzović Šarić V, Barberić M, Predović J, Rumenjak V, Cerovski B. Oxidative stress impact on growth hormone secretion in the eye. Croat Med J 2015;56:326-33. [PMID: 26321025 DOI: 10.3325/cmj.2015.56.326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]